Indiana University Indiana University IU

Open Search

Opioid ECHO

  • Home
  • About ECHO
  • COVID-19
  • Get Involved
  • Tracks
  • FAQ
  • Resources
  • Library
  • Our Team
  • Search
  • Prescribers & Dispensers
    • Expert Panel
    • Resources
  • Jail-Based Management
    • Expert Panel
    • Resources
    • Continuing Education
  • Pregnancy in OUD
    • Expert Panel
    • Resources
  • Case Management for OUD in Pregnancy
    • Expert Panel
    • Resources
  • NAS
    • Expert Panel
    • Resources
Past Clinics:
  • Adolescent
    • Expert Panel
    • Resources
  • Behavioral/ Psychotherapy Track
    • Expert Panel
    • Resources
  • Behavioral Health & Peer Recovery
    • Expert Panel
    • Resources
  • Early Childhood Home Visitors
    • Expert Panel
    • Resources
    • Literature
  • Emergency Room
    • Expert Panel
    • Resources
  • First Responders
    • Expert Panel
    • Resources
    • Continuing Education
  • Medical Co-Morbidities
    • Expert Panel
    • Resources

Prescribers & Dispensers Schedule

This free virtual clinic will meet every Wednesday from 12pm - 1:00pm EST.

The upcoming sessions are listed below. The topics covered in the remaining sessions will vary between cycles based on participant interests.

Register for this track here

Case presentations from participants are key parts of an ECHO clinic. You can submit a confidential, de-identified case by using this Qualtrics survey.

Schedule

Date Topic Presentation
1/5/2022 Introduction to MAT View
1/12/2022 The Role of a Pharmacist in MAT View
1/19/2022 Overview of Medicated Assisted Treatment & Data Waiver Requirements View
1/26/2022 Peer Recovery View
2/2/2022 Drug Testing/Patient Agreements/Non-compliance View
2/9/2022 Overview of Cognitive Behavior Therapy and DBT View
2/16/2022 Vivitrol and its Use View
2/23/2022 SUD in LGBTQ/OUD SUD Stigma View
3/2/2022 How OUD & MAT affects the Brain Chemistry View
3/9/2022 Overdose Lifeline -Short Guide to Harm Reduction View
3/16/2022 The latest Street Drugs; How to Detect; How to Treat; What are They Called View
3/23/2022 Peer Recovery Coach View
3/30/2022 Compliance & Monitoring Patients with OUD View
4/6/2022 AAA Program - Update on Diagnosis, Assessment and Treatment of Alcohol Use Disorder Part 1 Part 2
4/13/2022 Suicide risk assessment View Flyer
4/20/2022 Addressing Women and Addiction View
4/27/2022 Recovery Capital View Scale
5/4/2022 Introduction to MAT View
5/11/2022 Landlord Mitigation Reserve program / Recovery House & Oxford House Part 1 Part 2 Part 3
5/18/2022 Chronic Pain and OUD View
5/25/2022 Pharmacist Role in OUD View
6/1/2022 Pain management and Buprenorphine View
6/8/2022 Legal Issues in OUD and Resources for Pregnant Women with OUD In and Out of Incarceration Part 1 Part 2
6/15/2022 Drug Testing/Patient Agreements/Non-compliance & Landlord Mitigation Part 1 Part 2
6/22/2022 Addiction Therapy in Primary Care when patients won’t receive Counseling or MAT
6/29/2022 Harm Reduction Strategies
7/6/2022 Weaning MAT
7/13/2022 Effects of Adverse Childhood Experiences and Adult SUD
7/20/2022 Treatment of ADHD in SUD
7/27/2022 Anxiety disorder in Addictions
8/3/2022 Behavioral Health Interventions
8/10/2022 Drug Testing/Patient Agreements/Non-compliance
8/17/2022 Motivational Interviewing

Past Sessions (Sep 2021 - Dec 2021)

Date Topic Presentation
9/1/2021 CBD & the Endocannabinoid System View
9/8/2021 Tobacco Use Disorder View
9/15/2021 Engaging Adolescents in Treatment: Motivational Interviewing View
9/22/2021 Recovery Assist View
9/29/2021 Harm Reduction View
10/6/2021 MAT and Buprenorphine induction View
10/13/2021 Neurobiology View
10/20/2021 Pharmacist Role in MAT View
10/27/2021 Pharmacology View
11/3/2021 Drug Trends View
11/10/2021 Methamphetamine withdrawal and psychosis View
11/17/2021 Harm Reduction View
11/24/2021 [No session this week]
12/1/2021 Hidden drugs of abuse View
12/8/2021 Novel Drugs View
12/15/2021 TBD
12/22/2021 [No session this week]
12/29/2021 [No session this week]

Past Sessions (Sept 2020 - Aug 2021)

Date Topic Presentation
9/30/2020 Medications used for Alcohol Use Disorder View
10/7/2020 Legal Issues Related to OUD View
10/14/2020 [NO SESSION]
10/21/2020 How to treat OUD in patients with Traumatic Brain Injuries View
10/28/2020 Best Practices for SUD by Managed Care Companies View
11/4/2020 Treatments for Tobacco Use Disorder View
11/11/2020 Harm Reduction Strategies View
11/18/2020 Behavioral Health Interventions View
11/25/2020 [NO SESSION]
12/2/2020 Peer Recovery Coaching View
12/9/2020 Addressing Pain Management in OUD Patients View
12/16/2020 OUD & Suicide Risks View
1/6/2021 Indiana Recovery Housing Resources N/A
1/13/2021 Adverse Childhood Experiences Position Statement
1/20/2021 Pharmacists Role in the Treatment of OUD View
1/27/2021 Connection of Human Trafficking to SUD Position Statement
2/3/2021 Treating OUD in Primary Care Offices View
2/10/2021 Addressing Psychiatric Concerns in Primary Care Offices View
2/17/2021 General Overview of Stimulant Use Disorder and Affects on the Brain View
2/24/2021 Pharmacotherapy of Treating Stimulant Use Disorder and Stimulant Withdrawal View
3/3/2021 Treatment of Chronic Psychosis from Stimulants & Behavioral Interventions View
3/10/2021 Acute and Chronic Complications of Methamphetamine Use View
3/17/2021 Prescription Stimulant Abuse [Not Available]
3/24/2021 Contingency Management for the Treatment of Methamphetamine Use Disorder View
3/31/2021 Withdrawal and Cognitive Impairment of Opioid Use Disorder View
4/7/2021 [No Session]
4/14/2021 Legal Issues Related to OUD View
4/21/2021 Motivational Interviewing View
4/28/2021 Harm Reduction Strategies View
5/5/2021 Psychiatric Co-morbidities View
5/12/2021 Stigma Reduction View
5/19/2021 Overview of Medications used for the Treatment of OUD View
5/26/2021 Non-pharmacological Treatment of OUD View
6/2/2021 Long-acting Injectable Buprenorphine View
6/9/2021 Induction of Medications to Treat OUD View
6/16/2021 Buprenorphine Weaning and Tapering View
6/23/2021 Compliance & Monitoring Patients with OUD View
6/30/2021 Resiliency and Provider Self Care View
7/7/2021 [No session this week]
7/14/2021 Peer Support and Regional Recovery Hubs View
7/21/2021 Behavioral Health Interventions View
7/28/2021 Overview of Sythetic Cannabinoids View
8/4/2021 Pharmacists Role in Treatment OUD View
8/11/2021 Treatment in ED Settings View
8/18/2021 Treating Pain in Patients with OUD View
8/25/2021 Indiana Resources View

Past Sessions (Feb 2020 - Sept 2020)

Date Topic Presentation
February 12 Overview of MAT & Data Waiver View
February 19 Assessment of OUD View
February 26 Induction of MAT View
March 4 How OUD & MAT affect the brain View
March 11 Drug Testing/Patient agreement/non-compliance View
March 18 How to Prepare for DEA Audit View
March 25 SUD and COVID-19 View
April 1 Harm Reduction Strategies View
April 8 Telehealth View
April 15 Pharmacists Role in OUD View
April 22 COVID-19 MAT Prescribing Guidance View
April 29 ASAM COVID Resources View
May 6 Methamphetamines View
May 13 Peer Recovery Network - COVID Resources View
May 20 Compassionate Weaning of Opioids for Pain View
May 27 Sleep Hygiene View
June 3 Common Drug Trends View
June 10 Anxiety and SUD View
June 17 Motivational Interviewing 2.0 View
June 24 When and How to Taper Medications for OUD View
July 1 [No session]
July 8 NAMI Mental Health Resources View
July 15 Overview of Drug and Specialty Courts View
July 22 Overview and Induction of Medications used to treat OUD View
July 29 Long acting injectable Buprenorphine View
August 5 Treatment of OUD in those with Traumatic Brain Injuries View
August 12 Integrated Care Approach to treating OUD View
August 19 Screening for Traumatic Brain Injuries View
August 26 Compliance and Monitoring Patients on Medicated Assisted Treatment View
September 2 Overdose Awareness and Prevention View
September 9 A Case of Family Addiction - Effects on the Child View
September 16 INSPECT Updates – Indiana’s Prescription Monitoring Program N/A
September 23 Functional Analysis and other Behavioral Health Screening Tools View

Past Sessions (Sept 2019 - Feb 2020)

Date Topic Presentation
September 25 Overview of MAT & Data Waiver View
October 2 Assessment of OUD View
October 9 Induction of MAT View
October 16 [No clinic scheduled this week]
October 23 Methampetamines View
October 30 [No clinic scheduled this week]
November 6 Drug Testing/Patient agreement/non-compliance View
November 13 HIV & Hep C Testing and Screening View
November 20 Treatment in the Emergency Dept Setting View
December 4 SBIRT - Screening, Brief Intervention, Referral to Treatment View
December 11 Indiana Resources View
December 18 Indiana Rural Health Association Opioid Consortium View
January 8 CBD & the Endocannabinoid System View
January 15 Cognitive Behavioral Therapy View
January 22 Recovery Works View
January 29 Self Care and Compassion Fatigue View
February 5 OUD & Suicide View

Past Sessions (May 2019 - Sept 2019)

Date Topic Presentation
May 29 Overview of Medication-Assisted Treatment & Data Waiver Part 1 Part 2
June 5 Assessing and Diagnosing OUD View
June 12 Induction to MAT View
June 19 Drug Testing/Patient Agreements/Non-Compliance View
June 26 Neurobiology of OUD & MAT View
July 10 Stigma Reduction View
July 17 Legal Issued Related to OUD Patients View
July 24 Peer Recovery Support Services View
August 7 Harm Reduction Strategies View
August 14 Tobacco Cessation View
August 21 OUD in Pregnancy View
August 28 Addressing Chronic Pain in Patients with OUD View
September 4 Behavioral Interventions View
September 11 Co-Occurring Mental Health Conditions View
September 18 American Society of Addiction Medicine (ASAM) Guidelines View

For questions regarding the Opioid ECHO project, please contact Leah Coe, ECHO Program Management Coordinator, at oudecho@iu.edu

  • Follow us on Twitter
    Twitter

Indiana University

Accessibility | Privacy Notice | Copyright © 2022 The Trustees of Indiana University

  • Home
  • About ECHO
  • COVID-19
  • Get Involved
  • Tracks
  • FAQ
  • Resources
  • Our Team